Business Context and Reporting Period
This Form 10-QSB covers the quarterly period ended March 31, 2006, for Orthodontix, Inc. (Note: The input metadata referenced "Protalix Biotherapeutics," but the filing text explicitly identifies the issuer as Orthodontix, Inc.). The Company is a shell company with no active operating business, having terminated its affiliation with its founding orthodontic practices in 2001. Its primary objective is to consummate a merger or acquisition with an operating company.
Key Financial Metrics
| Metric | Q1 2006 | Q1 2005 |
|---|---|---|
| Revenue | $0 | $0 |
| Net Loss | $(11,247) | $(10,358) |
| Loss Per Share (Basic/Diluted) | $(0.00) | $(0.00) |
| General & Administrative Expenses | $21,111 | $10,863 |
| Interest Income | $9,864 | $505 |
| Cash and Cash Equivalents (End of Period) | $931,724 | $533,190 |
| Total Liabilities | $58,100 | N/A |
| Accumulated Deficit | $(3,823,929) | N/A |
| Net Cash Used in Operating Activities | $(53,514) | $(30,522) |
Material Changes vs. Prior Period
- Increased Operating Expenses: General and administrative expenses rose by approximately 94% (from $10,863 to $21,111), driven largely by director fees and accounting fees.
- Higher Interest Income: Interest income increased significantly to $9,864 from $505, attributable to the Company's cash being invested in certificates of deposit.
- Cash Position: Despite higher operating burn, the Company's cash balance increased substantially year-over-year due to prior capital raises and investment income, ending the quarter with $931,724.
- Share Count: The weighted average shares outstanding doubled from approximately 2.9 million in Q1 2005 to 5.8 million in Q1 2006.
Outlook, Risks, and Management Commentary
- Plan of Operation: Management is devoting substantially all time to identifying and consummating a business combination. Target industries include aircraft maintenance, health care, pharmaceuticals, and financial services.
- Liquidity: The Company believes its current cash reserves are sufficient to fund operations for at least the next twelve months. No debt financing is currently outstanding.
- Risks: There are no assurances that the Company will successfully locate a target, consummate a transaction on favorable terms, or that the combined entity will be profitable. The Company has no contractual commitments for an acquisition.
- Unusual Items: The Company is classified as a shell company. It has an accumulated deficit of over $3.8 million and relies entirely on interest income and existing cash reserves.
Investor Verification Checklist
- Shell Status: Verify the Company's status as a shell company with no operating revenue and its reliance on a future merger for viability.
- Cash Runway: Confirm the sufficiency of the $931,724 cash balance against the rising quarterly burn rate (approx. $53k cash used in operations).
- Related Party Transactions: Review the $4,450 accrued accounting fees owed to the CFO and $2,400 in director fees paid during the quarter.
- Bank Concentration Risk: Note that $705,650 of cash deposits exceeded federally insured limits as of March 31, 2006.
- Acquisition Progress: Monitor for any updates on specific merger targets, as the Company currently has no signed agreements.